Mufg Americas Holdings Corp Takeda Pharmaceutical CO LTD Transaction History

Mufg Americas Holdings Corp

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 09, 2022	SELL	$13.17 - $16.4 $11,405 - $14,202	-866 Closed	0 $0
Q3 2021 Dec 01, 2022	BUY	$16.3 - $17.26 $14,115 - $14,947	866 New	866 $14,000
Q3 2021 Nov 05, 2021	BUY	$16.3 - $17.26 $14,115 - $14,947	866 New	866 $14,000
Q3 2019 Nov 06, 2019	SELL	$16.15 - $17.99 $7,138 - $7,951	-442 Closed	0 $0
Q2 2019 Aug 09, 2019	SELL	$16.58 - $20.49 $18,436 - $22,784	-1,112 Reduced 71.56%	442 $8,000
Q1 2019 May 13, 2019	BUY	$16.7 - $21.52 $25,951 - $33,442	1,554 New	1,554 $32,000

337

73.8M

1.96M

165K

Ticker TAK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 3,109,050,112
Market Cap $42.2B
Description
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...

Get notified when there are updates to the investment portfolio of Mufg Americas Holdings Corp, based on Form 13F filings with the SEC.

Stay updated on Mufg Americas Holdings Corp with notifications on news.